The industry created to keep drug prices in check is capitalizing on a lack of government oversight to rake in huge profits, often at the expense of patients, health plans, and pharmacies, critics say. The culprits are companies called pharmacy benefit managers.
Trending:
PBM 'middlemen' drive up drug prices